Showing results (131-140 of 276) with videos related to

Sort By:
Pageof 28
Circulation|November 28, 2001
Time to treatment influences the impact of ST-segment resolution on one-year prognosis: insights from the assessment of the safety and efficacy of a new thrombolytic (ASSENT-2) trialY Fu, S Goodman, W C Chang, et al.
Journal of Biomedical Engineering|January 1, 1982
Relationship between apexcardiogram, left ventricular pressure and wall stressB G Denys, A E Aubert, B Denef, et al.
Acta Clinica Belgica|January 1, 1992
The role of percutaneous transvenous balloon mitral valvuloplasty in the treatment of patients with symptomatic mitral stenosisJ J Glazier, E Benit, M C Vrolix, et al.
Circulation|June 1, 1984
Diastolic properties of the left ventricle in normal adults and in patients with third heart soundsF Van de Werf, A Boel, J Geboers, et al.
Computer Methods and Programs in Biomedicine|December 1, 1999
The analysis of heart rate variability in unrestrained rats. Validation of method and resultsA E Aubert, D Ramaekers, F Beckers, et al.
Ultrasound in Medicine & Biology|February 27, 1999
Robustness of integrated backscatter for myocardial tissue characterizationB Bijnens, J D'Hooge, G Sutherland, et al.
International Journal of Cardiology|February 1, 1994
The brachial approach for intracoronary stent implantationN Stratigis, E Raymenants, M Vrolix, et al.
Circulation|September 1, 1995
Benefit of thrombolytic therapy is sustained throughout five years and is related to TIMI perfusion grade 3 but not grade 2 flow at discharge. The European Cooperative Study GroupT Lenderink, M L Simoons, G A Van Es, et al.
Circulation|October 1, 1990
Significance of initial ST segment elevation and depression for the management of thrombolytic therapy in acute myocardial infarction. European Cooperative Study Group for Recombinant Tissue-Type Plasminogen ActivatorJ L Willems, R J Willems, G M Willems, et al.
European Heart Journal|May 1, 1994
Early and late exercise capacity after acute myocardial infarction treated with recombinant tissue-plasminogen activatorT Brzostek, F Van de Werf, L Mortelmans, et al.
Pageof 28